Cargando…
Subjective Cognitive Decline as a Preclinical Marker for Alzheimer's Disease: The Challenge of Stability Over Time
Autores principales: | Ávila-Villanueva, Marina, Fernández-Blázquez, Miguel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696596/ https://www.ncbi.nlm.nih.gov/pubmed/29201004 http://dx.doi.org/10.3389/fnagi.2017.00377 |
Ejemplares similares
-
How to Prevent and/or Revert Alzheimer’s Disease Continuum During Preclinical Phases
por: Ávila-Villanueva, Marina, et al.
Publicado: (2023) -
The preservation of right cingulum fibers in subjective cognitive decline of preclinical phase of Alzheimer’s disease
por: Sun, Yu, et al.
Publicado: (2023) -
The Role of Chronic Stress as a Trigger for the Alzheimer Disease Continuum
por: Ávila-Villanueva, Marina, et al.
Publicado: (2020) -
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
por: Wang, Xiaoqi, et al.
Publicado: (2020) -
Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
por: Yu, Xianfeng, et al.
Publicado: (2023)